1.
Reply to Comment on: "Quality of Life in Primary Open-Angle Glaucoma and Cataract: An Analysis of VFQ-25 and OSDI from the iStent inject® Pivotal Trial".
Samuelson Thomas W, Singh Inder Paul, Williamson Blake K, Falvey Heather, Katz L Jay, Lee Won Chan et al.
Am J OphthalmolOct 20212 citationsLetter